Horizon Pharma plc 4/A
4/A · Horizon Pharma plc · Filed May 10, 2017
Insider Transaction Report
Form 4/AAmended
Nohria Virinder
Director
Transactions
- Exercise/Conversion
Restricted Stock Units
2017-05-03−13,953→ 0 total→ Ordinary shares (13,953 underlying) - Exercise/Conversion
Ordinary Shares
2017-05-03+13,953→ 19,211 total(indirect: By Trust)
Holdings
- 189,836
Ordinary Shares
Footnotes (2)
- [F1]Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer.
- [F2]On May 3, 2016, the reporting person was granted 13,953 restricted stock units, vesting in full on the first anniversary of the grant date.